Reduced DEFA5 Expression and STAT3 Activation Underlie the Submucosal Invasion of Early Gastric Cancers

Digestion. 2023;104(6):480-493. doi: 10.1159/000531790. Epub 2023 Aug 18.

Abstract

Introduction: Submucosal invasion is a core hallmark of early gastric cancer (EGC) with poor prognosis. However, the molecular mechanism of the progression from intramucosal gastric cancer (IMGC) to early submucosal-invasive gastric cancer (SMGC) is not fully understood. The objective of this study was to identify genes and pathways involved in the submucosal invasion in EGC using comprehensive gene expression analysis.

Methods: Gene expression profiling was performed for eight cases of IMGC and eight cases of early SMGC with submucosal invasion ≥500 μm. To validate the findings of gene expression analysis and to examine the gene expression pattern in tissues, immunohistochemical (IHC) staining was performed for 50 cases of IMGC and SMGC each.

Results: Gene expression analysis demonstrated that the expression levels of small intestine-specific genes were significantly decreased in SMGC. Among them, defensin alpha 5 (DEFA5) was the most downregulated gene in SMGC, which was further validated in SMGC tissues by IHC staining. Gene set enrichment analysis showed a strong association between SMGC, the JAK-STAT signaling pathway, and the upregulation of STAT3-activating cytokines. The expression of phosphorylated STAT3 was significant in the nucleus of tumor cells in SMGC tissues but not in areas expressing DEFA5.

Conclusion: The results of this study strongly suggest that the downregulation of DEFA5 and the activation of STAT3 play a significant role in the submucosal invasion of EGC.

Keywords: DEFA5; Gastric cancer; STAT3; Submucosal invasion.

MeSH terms

  • Gastrectomy / methods
  • Gastric Mucosa / pathology
  • Gene Expression Profiling
  • Humans
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology
  • Retrospective Studies
  • STAT3 Transcription Factor / genetics
  • Stomach Neoplasms* / pathology

Substances

  • STAT3 protein, human
  • STAT3 Transcription Factor

Grants and funding

This work was supported by Grant-in-Aid for Early-Career Scientists (Grant Nos. 22K15959 and 21K15479), from the Japan Society for the Promotion of Science.